Дисертації з теми "Organ Transplant Recipient"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-21 дисертацій для дослідження на тему "Organ Transplant Recipient".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте дисертації для різних дисциплін та оформлюйте правильно вашу бібліографію.
Paris, Wayne. "Organ transplant recipient employment perception." Thesis, University of Huddersfield, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.430282.
Повний текст джерелаFalk, Rachel E. "Identity and adjustment : experiences of the organ transplant recipient." Thesis, Canterbury Christ Church University, 2015. http://create.canterbury.ac.uk/14079/.
Повний текст джерелаEvertsson, Elvira, and Åsa Dunder. "Organmottagares upplevelse av att ha genomgått en hjärttransplantation : En litteraturbaserad studie." Thesis, Högskolan i Skövde, Institutionen för hälsa och lärande, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-16761.
Повний текст джерелаBackground: The first heart transplant performed in Sweden took place in 1984 in Gothenburg. An increasing trend has been identified over the years and Sweden is the country that performs most heart transplants in Scandinavia. It is in case of severe heart failure that the affected person can become a candidate for any heart transplant and the nurse has a key role in the care of these patients. The purpose of nursing is to improve the patient's chance of survival and quality of life. Aim: The aim was to describe the organ recipient’ experience after having a heart transplant. Method: A literature-based study where the data consisted of qualitative articles. Result: Four categories were identified; A new life situation, changed view of life, influence from others and new thoughts about the future with ten subcategories. Conclusion: The result shows that patients who have undergone a heart transplant experience a changed everyday life and belief. New insights about life and the experience of having a new chance created. This arouses a sense of gratitude and obligation towards their donor. The majority of the patients felt that the support from the health service was inadequate, both before and after the surgery and that it is the lack of information that is perceived as central.
Totti, Valentina <1986>. "Exercise and sport for health in solid organ transplant recipients." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2020. http://amsdottorato.unibo.it/9222/1/PhD%20Thesis%20Totti%20V..pdf.
Повний текст джерелаMankowski, Sophie. "Personality predictors of post-transplant health outcomes in solid organ recipients." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape15/PQDD_0015/MQ37586.pdf.
Повний текст джерелаHumphrey, Heather. "Current Practices in Music Therapy with Bone Marrow and Organ Transplant Recipients." UKnowledge, 2016. http://uknowledge.uky.edu/music_etds/65.
Повний текст джерелаHaque, Tanzina. "Longitudinal study on Epstein-Barr Virus (EBV) infection in solid organ transplant recipients." Thesis, London School of Hygiene and Tropical Medicine (University of London), 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.283206.
Повний текст джерелаGarrett, Giorgia L., Paul D. Blanc, John Boscardin, Amanda Abramson Lloyd, Rehana L. Ahmed, Tiffany Anthony, Kristin Bibee, et al. "Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States." AMER MEDICAL ASSOC, 2017. http://hdl.handle.net/10150/623191.
Повний текст джерелаTang, James. "Patient-centred digital technology to improve self-management and health outcomes in solid organ transplant recipients." Thesis, The University of Sydney, 2021. https://hdl.handle.net/2123/27380.
Повний текст джерелаYe, X., J. N. Van, F. M. Munoz, P. A. Revell, Claudia A. Korinetz, R. A. Krance, R. L. Atmar, M. K. Estes, and H. L. Koo. "Noroviruses as a Cause of Diarrhea in Immunocompromised Pediatric Hematopoietic Stem Cell and Solid Organ Transplant Recipients." Digital Commons @ East Tennessee State University, 2015. https://dc.etsu.edu/etsu-works/1490.
Повний текст джерелаAndersson, Sara, and Maria Cramér. "Att leva med ett organ från en avliden donator - en humanbecoming." Thesis, Högskolan i Halmstad, Akademin för hälsa och välfärd, 2018. http://urn.kb.se/resolve?urn=urn:nbn:se:hh:diva-36743.
Повний текст джерелаThe need for organ transplants has risen considerably, that is why there are more organ transplants carried out each year. To acquire a new organ means for many that somebody has to die during circumstances that an organ can be donated and the donor or their relatives must have a will to donate their organ. The transplant process is long and doesn't end when the new organ is transplanted, in addition to lifelong medication there can be many thoughts and questions that can arise. The purpose of this study was to describe the patients experience to live with an organ from a deceased donor. The study was carried out like a general literature study. The ten resulting articles were assessed, compiled and resulted in the following five themes: Experience of gratefulness, Experience of responsibility to the donator, Experience of a changed self, Experience of guilt and Experience of grief. The main findings from the study is that the recipient experiences a change in their self and experience of gratefulness. A wider understanding around the recipient experiences after a transplant with an organ from a deceased donor, where personal treatment is needed to support the requirements.
O'Driscoll, Catherine T. "A study to determine the quality of life and experiences for liver and kidney transplant recipients and living kidney donors in Western Australia : the economic implications." University of Western Australia. School of Surgery, 2008. http://theses.library.uwa.edu.au/adt-WU2009.0077.
Повний текст джерелаKelly, Mary Johanna. "A grounded theory study of the issues and challenges that impact on transplant coordinators and their practice." 2008. http://hdl.handle.net/2440/46912.
Повний текст джерелаhttp://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1311520
Thesis (Ph.D.) -- University of Adelaide, School of Population Health and Clinical Practice, 2008
Kelly, Mary Johanna. "A grounded theory study of the issues and challenges that impact on transplant coordinators and their practice." Thesis, 2008. http://hdl.handle.net/2440/46912.
Повний текст джерелаThesis (Ph.D.) -- University of Adelaide, School of Population Health and Clinical Practice, 2008
Chia-Jung, Chan, and 詹佳蓉. "Mental and Physical Changes in Organ Transplant Recipients." Thesis, 2006. http://ndltd.ncl.edu.tw/handle/61974657207157971340.
Повний текст джерела臺北醫學大學
醫學人文研究所
94
In Taiwan, organ transplantation has become a choice of treatments for end-stage organ diseases. After the success of transplantation surgery, the patients must face mental and physical pressure, challenge of social adjustment, personal economic problems and even the near-death experience. Besides, the receivers have to encounter the death of the donators while getting the surviving organs. The process of receiving a new organ is deeply mentally and socially influenced. As a result, the purpose of this study is trying to understand the mental and physical changes of the receivers, and also, to realize how they recognize, through the new organs, the relationship between themselves and the donators. How do they think about their donators? What are the factors that influence the images and conception of their donators? The study used qualitative method to interview 11 receivers of different organs, and, in the viewpoint of the patients, inspected their physical and mental changes in the hope of trying to get more true thoughts and feelings of the patients themselves. The result of the study showed that the patients’ short-term appearance changes caused by steroid taken after surgery have recovered to normal in about 6 months. In addition, the “recovery of the physical power” was the prominent physical improvement confirmed by all organ receivers. Receivers of liver transplantation even reached the functional level of common healthy people. “Fear” was the major feeling of heart and lung receivers in the initial period when new organs began to work in their bodies. They affirmed that the organs they had received are the most important organ among all. Good doctor-patient relationship and the transplantation patient groups both enhanced medical compliance. Interaction between patients helps provide mental support. Regarding patients’ interaction, the sequence of transplantation surgery plays an important role. The factors influencing the patients’ mental and physical status after the transplantation surgery are as the followings: health condition (which may cause change in life style), traumatic experiences during operation, reconsideration about life meaning, attributing the whole process to religious implication, thoughts about donators. Most receivers avoided talking about their donators .Which might be caused by medical concepts imposed during medical treatment process in the hospital system.
Ling, You-Li. "Outcomes and expenditures of clostridium difficile infection in pediatric solid organ transplant recipients." Thesis, 2014. http://hdl.handle.net/2152/26474.
Повний текст джерелаtext
Kimberly, Laura L. "Older Adult Kidney Transplant Recipients: The Lived Experience of Adaptation and Integration." Thesis, 2020. https://doi.org/10.7916/d8-xg6z-t744.
Повний текст джерелаYang, Fu-Chi, and 楊馥綺. "The Dilemma and Needs of Taiwan's Critical Care Nurses in Taking Care of Organ Transplant Recipients." Thesis, 2009. http://ndltd.ncl.edu.tw/handle/04127308212617173767.
Повний текст джерела國立陽明大學
臨床暨社區護理研究所
97
Background In caring for the organ transplant (OT) donors and recipients, critical care nurses (CCN) are always challenged to effectively manage complex caring situations related to organ donors, recipients, their families, nursing and interdisciplinary health team members. It is important to learn their perspectives of caring dilemmas, needed helps, coping strategies between young and senior nurses. Purpose The purposes of this study were to explore CCN’s perspective of their caring dilemma for organ transplant donors and recipients, their needed help, and coping strategies between young and senior nurses. Method A qualitative exploratory study was used. A purposive sample of CCN with experiences of OT was obtained from a leading medical center in Central Taiwan. With semi-structured interview guide, data were collected by in-depth face-to-face interviews, and analyzed by qualitative content analysis mode. Results A total of 30 CCN (29 females, 1 male) participated in this peoject. They were aged between 26 ~ 44 (M ± SD = 36.3 ± 4.5) years old. Twenty-one of them were married, and 9 were single. The majority graduated from university or college. Fourteen of them reported a belief of combination of Confucianism and Buddhism, 9 were Buddhists, 5 were non-believers, and others were Taoist or Christian. In terms of nursing professional status, 21 were occupational nurses, 5 were registered nurses, 2 were nurse practitioners, and others were head nurse or assistant head nurse. The years of nursing profession ranged between 3 ~ 22 (M = 13.8) years; the years of organ transplant nursing care ranged between 0.5 ~ 15 (M = 4.10) years. Finally, 26 received OT training programs, and the rest reported having no related training. Five caring dilemmas were reported as: (a) limitations in medical resources; (b) lacking of sound mental preparations; (c) insufficient OT professional care competence; (d) workload of caring; and (e) inefficient coordination and communication between OT team members. Several explicit needed help were identified as: (a) a functional OT center and long-term OT caring team; (b) improvement in medical equipments and materials; (c) holding periodical single/multiple OT case conference and forum; (d) bereavement care for the donors’ and recipient’s family; (e) OT nursing care standard operating procedure (SOP); (f) comprehensive humanistic training program; (g) comprehensive OT in-service training programs; (h) opportunities of national and/or overseas advanced OT training for senior CCN; (I) encouragement from peers, superiors, and medical team members; (j) stress-managing protocols for CCN; (k) sufficient nursing manpower in multi-organ transplant ICUs; (l) recruiting more young RNs to learn OT care; (m) reasonable work shifts; (n) reimbursement for overtime-work; (o) consensus among physician, CCN and other OT team members; (p) precise caring guidance and decision-making; and (q) coordination efforts from social workers. The coping strategies for needed help were: (a) arousing hospital administrators’ attentions to update OT policies; (b) asking hospitals to provide safe caring environment; (c) holding case conference for successful and failed cases; (d) developing clinical paths for multiple OT cases; (e) establishing long-term team for multiple OT cases; (f) implementing humanistic caring training program; (g) hosting systematical OT in-service training program; (h) offering professional certification for OT CCN; (i) asking hospital to offer reasonable payment systems for OT CCN; (j) asking hospital to offer reasonable manpower systems for OT CCN; (k) establishing coaching systems for OT CCN; (l) searching for available resources; and (m) inviting assistance from social workers. Finally, the perspectives between the young and senior CCN were further compared and discussed. Conclusions The project explored and compared Taiwan’s OT CCN’s perspectives of their caring dilemmas for OT clients, their needed help, and coping strategies for the difficulties. The findings between young and senior CCN’s groups are not identical. The nurse educators and administrators are suggested to develop related programs and administrative support to meet this particular group’s multiple needs. With the reasonable direct and indirect caring systems, and tangible as well as psychological support, OT CCN will be encouraged to devote them to OT care; the functional interdisciplinary OT team will also be established. Finally, the quality of OT care will then be ensured. Keywords: critical care nurses, young and senior nurse, organ transplant caring dilemmas, needed help, coping strategies, explorative qualitative study
Huang, Yu-Hsuan, and 黃聿璿. "Drug Interaction with Cyclosporine and Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir Regimen for HCV in Organ Transplant Recipients." Thesis, 2018. http://ndltd.ncl.edu.tw/handle/2qhqsa.
Повний текст джерела國立陽明大學
藥理學研究所
106
Background: Hepatitis C virus (HCV) infection affects millions of individuals worldwide, especially for those who have received organ transplantation. Direct-acting antiviral agents (DAAs) as a combination regimen to treat chronic HCV infection have been proven to be effective. Paritaprevir/ritonavir/ombitasvir/dasabuvir are component of the therapy regimen for HCV genotype (GT) 1 infection. It resulted in a high sustained virologic response (SVR) rate and few side effects though it needed to concern drug interaction if used on organ transplant recipients. Cyclosporine (CsA) is a key immunosuppressant after organ transplantation. Because paritaprevir/ritonavir/ombitasvir/dasabuvir regimen and CsA are both metabolized via cytochrome P450 (CYP) 3A and P-glycoprotein, coadministration of these drugs may result in serious drug interactions. Package insert of paritaprevir/ritonavir/ombitasvir/dasabuvir regimen and recent studies suggest the CsA dose should be reduced to one-fifth of the previous total daily dose and administered once-daily when initiating paritaprevir/ritonavir/ombitasvir/dasabuvir regimen. However, we found this dose recommendation of CsA could not fit Taiwanese organ transplant recipients. Furthermore, there is a paucity of data regarding dose and frequency recommendation for CsA when paritaprevir/ritonavir/ombitasvir/dasabuvir regimen is completed. The research about the safety and efficacy of paritaprevir/ritonavir/ombitasvir/dasabuvir regimen in Taiwanese organ transplant recipients is also absent. Thus, we conducted this study to evaluate the pharmacokinetics change of CsA. Moreover, the safety and efficacy of paritaprevir/ritonavir/ombitasvir/dasabuvir regimen among Taiwanese organ transplant recipients taking CsA were also assessed. Method: We conducted a retrospective study using Taipei Veterans General Hospital electronic medical records. Between January 2017 and September 2017, the patients who are organ transplant recipients under regular CsA regimen, were diagnosed with HCV infection and received paritaprevir/ritonavir/ombitasvir/dasabuvir regimen were enrolled. The non-compartmental method was used to calculate the pharmacokinetics parameters of CsA. Simulated concentration-time profile for paritaprevir/ritonavir/ombitasvir/dasabuvir regimen plus CsA to determine whether the CsA dose regimen as appropriate by using nonparametric super-positioning. The mixed effect model was utilized to assess the effect of paritaprevir/ritonavir/ombitasvir/dasabuvir regimen on CsA and test the difference in laboratory data for the safety evaluation. The data of HCV viral load were collected for the efficacy assessment. Result: Seven patients were enrolled into our study, including 5 kidney transplant recipients and 2 liver transplant recipients. In the presence of paritaprevir/ritonavir/ombitasvir/dasabuvir regimen on the first day, dose-normalized CsA AUC∞ was 5.18-fold when CsA administered alone, respectively. CsA half-life increased from 5.1 to 12.6 hours. When the steady state of paritaprevir/ritonavir/ombitasvir/dasabuvir regimen is reached, CsA dose-normalized AUC∞ were 6.82-fold of the CsA values when administered alone, and CsA half-life increased from 5.1 to 17.1 hours. From simulated concentration-time curve, a reduction in CsA dose and dosing frequency is sevenfold reduction in total daily dose to achieve Ctrough values similar to those observed before paritaprevir/ritonavir/ombitasvir/dasabuvir regimen. The readjustments of CsA for all patients were done within 7 days after the paritaprevir/ritonavir/ombitasvir/dasabuvir regimen is completed. For safety issue, there were no significant deterioration of liver and kidney function. Adverse events for fatigue in one patient, headache in one patient, malaise in one patient and diarrhea in one patient. No episode of graft rejection or patient mortality was observed during the treatment. Six patients achieved rapid virologic response (RVR), and all patients achieved end-of-treatment response (ETR) and sustained virologic response at 12 week (SVR12). Conclusion: When initiating therapy with paritaprevir/ritonavir/ombitasvir/dasabuvir regimen, the CsA dose should be reduced to one-seventh of the previous total daily dose in 70 percentage of Taiwanese organ transplant recipients, with close monitoring of CsA Ctrough to determine subsequent dose modifications. The CsA dose should be resumed within 7 days when the paritaprevir/ritonavir/ombitasvir/dasabuvir regimen completed, followed by frequent therapeutic drug monitoring to maintain appropriate CsA concentration (50-100 ng/ml). The safety and efficacy of paritaprevir/ritonavir/ombitasvir/dasabuvir regimen in Taiwan organ transplant recipients were not inferior to Caucasians. Key words: HCV, paritaprevir/ritonavir/ombitasvir/dasabuvir regimen, organ transplantation, cyclosporine, pharmacokinetics, Asian
Adamson, Carisa Harris. "Glucoregulation during an acute bout of exercise in post pancreatic-kidney transplant recipients." 2002. http://www.oregonpdf.org.
Повний текст джерелаDelgado, Lucinda Amorim Ramos de Lonet. "Carcinoma pulmonar em doentes com transplante de órgão sólido." Master's thesis, 2020. http://hdl.handle.net/10316/97723.
Повний текст джерелаA transplantação de órgão sólido é, atualmente, uma oportunidade terapêutica para diversas doenças em fase terminal que afetam órgãos como o coração, fígado, rim, pulmão e pâncreas. Apesar dos resultados cada vez mais promissores, existem inúmeras complicações resultantes dos regimes imunossupressores e do aumento da sobrevida. Uma das complicações tardias mais frequentes e também causa de elevada mortalidade é a doença oncológica. Porém, dentro deste grupo a incidência do carcinoma pulmonar em doentes transplantados é controversa.Deste modo, o objetivo desta revisão da literatura, foi explorar a possível relação entre doentes com transplante de órgão sólido e o posterior desenvolvimento de carcinoma pulmonar. Adicionalmente, foram também investigadas possíveis causas para esta associação.Para a elaboração deste trabalho, foi realizada uma pesquisa nas bases de dados PubMed e Web of Science, com restrição para artigos redigidos em inglês, português e espanhol, com data de publicação entre 2008 e 2019, inclusive.Vários estudos demonstraram que doentes com transplante cardíaco, hepático ou pulmonar tiveram uma incidência superior de cancro do pulmão em relação à população geral. Relativamente aos doentes com transplante renal, diversos autores consideraram que a incidência de carcinoma pulmonar nestes doentes foi semelhante à da população geral.O tabagismo permaneceu como principal fator de risco para o desenvolvimento de carcinoma pulmonar em doentes transplantados. Entre outros fatores etiologicamente relacionados destacam-se a idade avançada, o álcool na transplantação hepática e a fibrose pulmonar idiopática ou enfisema em doentes com doença pulmonar obstrutiva crónica na transplantação pulmonar.O seguimento destes doentes é fulcral para que seja realizado um diagnóstico precoce do cancro do pulmão, com consequente aumento da sobrevida. Alguns autores aconselham o uso da tomografia computorizada torácica de baixa dose em doentes com risco superior para o desenvolvimento de cancro do pulmão após transplante de órgão sólido.
Solid organ transplantation is a therapeutic option for patients with end-stage organ disease. Despite the promising results, there are several complications associated with immunosuppressive strategies and patient survival. Post-transplant malignancy is a common late complication and an important cause of mortality. However, the incidence of lung cancer in transplant recipients is controversial.The goal of this literature review was to explore the possible relationship between solid organ transplantation and the later development of lung cancer. Following this association, the possible causes that may support this relationship were also reviewed.The research was done using the PubMed and Web of Science databases, with two restrictions. One was made to insure that only articles written in English, Portuguese and Spanish, would appear. The other was to limit the search results to articles published between, 2008 and 2019, including both years.Several studies have shown that in people which have undergone a cardiac, liver or lung transplant, the incidence of lung cancer was higher than general population. Regarding kidney transplant recipients, several authors have considered that the incidence of lung cancer in these patients was similar to the general population.Smoking remained the main risk factor for the development of post-transplant lung cancer. Other risk factors identified were advanced age, alcohol for liver transplant and idiopathic pulmonary fibrosis or emphysema in patients with chronic obstructive pulmonary disease for lung transplant.The follow-up of these patients is crucial for an early detection of lung cancer, with a significant improvement in patient’s survival rates. Some authors consider that, after solid organ transplantation, patients with high-risk to develop lung cancer should be screened with low-dose chest computed tomography.